A TLR7 agonist trifluoroacetate, Crystal form B, Preparation Process and use

• 收藏
• 分享

专利权人:

LTD;CHIA TAI TIANQING PHARMACEUTICAL GROUP CO.

发明人:

DING, Zhaozhong,SUN, Fei,YANG, Ling,HU, Yinghu,ZHOU, Yilong,WANG, Zheng,ZHAO, Rui,DING ZHAOZHONG,SUN FEI,YANG LING,HU YINGHU,ZHOU YILONG,WANG ZHENG,ZHAO RUI

申请号：

CL2018002101

公开号：

CL2018002101A1

申请日:

2018.08.03

申请国别(地区):

CL

年份:

2018

代理人:

摘要：

The present Invention relates to a 2–butoxi–7– trifluoroacetate (4 - (pirrolidin–1–ilmetil) benzyl) [] –5h–pirrolo 3,2–d pirimidin–4–amina as TLR7 agonist (formula I), The Crystal Form bThe process of Preparation and their use.<；p>；LA PRESENTE INVENCIÓ；N SE REFIERE A UN TRIFLUOROACETATO DE 2&ndash；BUTOXI&ndash；7&ndash； (4&ndash；(PIRROLIDIN&ndash；1&ndash；ILMETIL)BENCIL)&ndash；5H&ndash；PIRROLO[3,2&ndash；D]PIRIMIDIN&ndash；4&ndash；AMINA COMO AGONISTA DE TLR7 (FÓ；RMULA I), LA FORMA CRISTALINA B, EL PROCESO DE PREPARACIÓ；N Y SU UTILIZACIÓ；N.<；/p>；

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/